Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M338,645Revenue (TTM) $M71,890Net Margin (%)22.8Altman Z-Score5.3
Enterprise Value $M323,864EPS (TTM) $5.9Operating Margin %29.4Piotroski F-Score8
P/E(ttm)21.2Beneish M-Score-2.5Pre-tax Margin (%)27.6Higher ROA y-yY
Price/Book4.810-y EBITDA Growth Rate %3.9Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %9.1Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow22.4y-y EBITDA Growth Rate %4.3ROA % (ttm)11.9Higher Current Ratio y-yY
Dividend Yield %2.6PEG2.3ROE % (ttm)22.8Less Shares Outstanding y-yY
Payout Ratio %53.0Shares Outstanding M2,711ROIC % (ttm)31.2Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

JNJ is held by these investors:



JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Duato JoaquinExec VP, WW Chair, Pharma 2017-03-03Sell50,000$123.621.05view
Kapusta Ronald AController, CAO 2017-02-28Sell14,543$122.262.18view
Pruden Gary JExec VP, WW Chair, Med Devices 2017-02-28Sell16,299$122.212.22view
Stoffels PaulusExec VP, Chief Scientific Off 2017-02-15Sell22,000$117.296.51view
Ullmann Michael HExec VP, General Counsel 2017-02-01Sell21,735$112.8810.67view
PRINCE CHARLESDirector 2016-10-21Buy875$114.119.47view
Caruso Dominic JExec VP, Finance; CFO 2016-07-26Sell41,146$125.01-0.07view
Kapusta Ronald AController, CAO 2016-07-22Sell2,935$125.01-0.07view
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.037.66view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.797.88view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    The Threat and Risk of Rising Interest Rates: Separating Fact From Fiction Mar 24 2017 
    4 Biotech Stocks to Watch Mar 22 2017 
    What You Need to Know About the March Rate Hike Mar 20 2017 
    Will Apple Be the Next AAA-Rated Company? Mar 20 2017 
    Compound Interest Is Real Modern-Day Alchemy Mar 19 2017 
    US Market Indexes Gain and Fed Raises Rate Mar 15 2017 
    Case Study: Insider Ownership Among Dividend Kings Mar 15 2017 
    6 Signs of a Shareholder-Friendly Stock Mar 13 2017 
    US Market Indexes Close Higher Mar 10 2017 
    The Risks and Double Compounding Potential Mar 09 2017 

    More From Other Websites
    [$$] Celgene, JNJ Lead Multiple Myeloma Mar 29 2017
    Senator McCaskill Launching Investigation Into Opioid Drugmakers Mar 28 2017
    Opioid epidemic: Senate committee opens probe of five big painkiller makers Mar 28 2017
    U.S. senator launches probe into five top opioid drugmakers Mar 28 2017
    Johnson & Johnson just launched a $100,000 burnout prevention bootcamp for CEOs Mar 28 2017
    Why Is Achillion (ACHN) Down 11.3% Since the Last Earnings Report? Mar 28 2017
    Why Johnson & Johnson Would Like to Forget 2016: QuickTake Q&A Mar 28 2017
    J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe Mar 27 2017
    The $100,000 Anti-Burnout Program for CEOs Mar 27 2017
    5 Can't Miss Dividend Hikes Coming This Spring Mar 26 2017
    Can This Pharma Stock Withstand the 'Trump Effect'? Mar 25 2017
    More big brands pull ads from YouTube in widening boycott Mar 24 2017
    More big brands pull ads from YouTube in widening boycott Mar 24 2017
    Coca-Cola, Walmart Latest to Pull Ads From Google Amid Concerns About Offensive Content Mar 24 2017
    The Threat And Risk Of Rising Interest Rates: Separating Fact From Fiction Mar 24 2017
    The Threat and Risk of Rising Interest Rates: Separating Fact From Fiction Mar 24 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)